NEST

Neurorehabilitation Ecosystem for Sustained Therapy

An eHealth solution that supports at-home rehabilitation after stroke

A Targeted Approach

There are more than 15M cases of stroke every year, of which about 40% require motor and cognitive rehabilitation, leaving 6M new patients requiring treatment every year and more than 33M chronic patients worldwide. This massive incidence puts great pressure on healthcare systems.

  • By leveraging widely distributed technologies among the population, such as smartphones, smartwatches, PCs, and laptops, NEST provides affordable and scalable science-based solutions for tele-rehabilitation.

NEST will improve long-term recovery while allowing hospitals to reduce the length of outpatient treatment and its associated costs of infrastructure and staff, while maximizing the treatment capacity of therapists.

NEST will scale and generalize to provide treatment for several patient groups such as COVID-19, post- ICU, cardiovascular, trauma, multiple sclerosis, Parkinson’s, cerebral palsy, Alzheimer’s patients, and the elderly population in need to fight muscle weakness and cognitive decline.

NEST Concept

The driving concepts of NEST are environmental enrichment, embodied interaction and proximal and distal goals serving wellbeing through the execution of Activities of Daily Living.

DATA-DRIVEN SOLUTIONS

Research

NEST will improve long-term recovery while allowing hospitals to reduce the length of outpatient treatment and its associated costs of infrastructure and staff, while maximizing the treatment capacity of therapists.

 

READ THE LATEST RESEARCH

The NEST System

The NEST platform includes the RGSapp (smartphone) to access rehabilitation exercises and the RGS-wear for continuous monitoring. Via its AI-based architecture, the AWA Coach provides autonomous personalized health advice, monitoring, and interventions in the form of structured and unstructured motor and cognitive tasks in a physical and social context. 

Impact

NEST will scale and generalize to provide treatment for several patient groups such as COVID-19, post- ICU, cardiovascular, trauma, multiple sclerosis, Parkinson’s, cerebral palsy, Alzheimer’s patients, and the elderly population in need to fight muscle weakness and cognitive decline.

Work with us

Are interested to know more about the NEST clinical study?